Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 41
Filter
1.
J Histochem Cytochem ; 72(5): 289-307, 2024 05.
Article in English | MEDLINE | ID: mdl-38725414

ABSTRACT

Several types of cytotoxic insults disrupt endoplasmic reticulum (ER) homeostasis, cause ER stress, and activate the unfolded protein response (UPR). The role of ER stress and UPR activation in hypersensitivity pneumonitis (HP) has not been described. HP is an immune-mediated interstitial lung disease that develops following repeated inhalation of various antigens in susceptible and sensitized individuals. The aim of this study was to investigate the lung expression and localization of the key effectors of the UPR, BiP/GRP78, CHOP, and sXBP1 in HP patients compared with control subjects. Furthermore, we developed a mouse model of HP to determine whether ER stress and UPR pathway are induced during this pathogenesis. In human control lungs, we observed weak positive staining for BiP in some epithelial cells and macrophages, while sXBP1 and CHOP were negative. Conversely, strong BiP, sXBP1- and CHOP-positive alveolar and bronchial epithelial, and inflammatory cells were identified in HP lungs. We also found apoptosis and autophagy markers colocalization with UPR proteins in HP lungs. Similar results were obtained in lungs from an HP mouse model. Our findings suggest that the UPR pathway is associated with the pathogenesis of HP.


Subject(s)
Alveolitis, Extrinsic Allergic , Endoplasmic Reticulum Chaperone BiP , Endoplasmic Reticulum Stress , Epithelial Cells , Heat-Shock Proteins , Transcription Factor CHOP , Unfolded Protein Response , X-Box Binding Protein 1 , Animals , Alveolitis, Extrinsic Allergic/pathology , Alveolitis, Extrinsic Allergic/immunology , Alveolitis, Extrinsic Allergic/metabolism , Humans , Mice , X-Box Binding Protein 1/metabolism , X-Box Binding Protein 1/genetics , Heat-Shock Proteins/metabolism , Transcription Factor CHOP/metabolism , Epithelial Cells/metabolism , Epithelial Cells/pathology , Female , Male , Lung/pathology , Lung/immunology , Lung/metabolism , DNA-Binding Proteins/metabolism , Regulatory Factor X Transcription Factors/metabolism , Transcription Factors/metabolism , Disease Models, Animal , Middle Aged , Mice, Inbred C57BL , Adult , Inflammation/pathology , Inflammation/metabolism , Inflammation/immunology
2.
Ethics Hum Res ; 45(2): 35-39, 2023 Mar.
Article in English | MEDLINE | ID: mdl-36974456

ABSTRACT

Guidelines from the Office for Human Research Protections regarding categories of research that institutional review boards (IRBs) may review through expedited procedures limit the volume of blood that can be obtained from research participants for minimal risk research purposes. As defined by the Common Rule, minimal risk research is research in which the probability and magnitude of harm or discomfort anticipated are not greater than the probability and magnitude of harm or discomfort encountered from routine clinical tests. For this study, we considered the volume of remnant blood following routine clinical tests in light of the current definition of minimal risk in research. Conducted at a single institution, this was a prospective cross-sectional study that evaluated blood draws from 122 patients. The median daily remnant blood volume was 11.6 (interquartile range [IQR]: 12.3, 15.2) ml for all patients and 12.9 (IQR: 13.1, 16.9) ml for patients admitted to the intensive care unit. Our findings regarding daily remnant blood volume suggest that the currently allowable blood-volume limits to qualify for expedited review or to qualify as not more than minimal risk research involving blood draws from nonhealthy adults are less than what patients experience in routine medical testing. These findings support permitting an increase in the allowable blood-volume limits to meet the regulatory definition of minimal risk research for obtaining expedited IRB review of studies in which blood samples will be collected.


Subject(s)
Ethics Committees, Research , Phlebotomy , Adult , Humans , Cross-Sectional Studies , Prospective Studies , Risk
3.
Angew Chem Int Ed Engl ; 62(17): e202218555, 2023 Apr 17.
Article in English | MEDLINE | ID: mdl-36828774

ABSTRACT

After more than three decades of extensive investigations on supramolecular polymers, strategies for self-limiting growth still remain challenging. Herein, we exploit a new V-shaped monomer design to achieve anticooperatively formed oligomers with superior robustness and high luminescence. In toluene, the monomer-oligomer equilibrium is shifted to the monomer side, enabling the elucidation of the molecular packing modes and the resulting (weak) anticooperativity. Steric effects associated with an antiparallel staircase organization of the dyes are proposed to outcompete aromatic and unconventional B-F⋅⋅⋅H-N/C interactions, restricting the growth at the stage of oligomers. In methylcyclohexane (MCH), the packing modes and the anticooperativity are preserved; however, pronounced solvophobic and chain-enwrapping effects lead to thermally ultrastable oligomers. Our results shed light on understanding anticooperative effects and restricted growth in self-assembly.

4.
Water Res ; 220: 118593, 2022 Jul 15.
Article in English | MEDLINE | ID: mdl-35671683

ABSTRACT

An industrial ceramic nanofiltration membrane (pore size 0.9 nm) was tested in a Canadian oil field for more than 12,500 h to treat wastewater directly from daily operations, without any type of pre-treatment. This wastewater contained a high content of total suspended solids (13 to 510 mg/kg), and total organic carbon (31 to 134 mg/kg). The membrane unit was operated at different transmembrane pressure (TMP) set points (4-16 bar) and recovery set points (40-80%). The data show that ion and compound rejection depend strongly on a combination of both TMP and recovery, with the largest rejection occurring at low recovery values and high TMP values. Two mechanisms were responsible for rejection: sieving, which mostly impacted compound rejection, and electrostatic phenomena that impacted ion rejection. It is shown that ion rejection depends linearly on charge density of the ion. Ion rejection was measured as high as 85% and compounds (such as TSS) were rejected as high as 100%. The specific flux varied between 1-10 L/(m2.h.bar). Results from this field testing indicate the possibility of using these types of ceramic membranes for oil field wastewater treatment.


Subject(s)
Wastewater , Water Purification , Canada , Ceramics , Filtration/methods , Membranes, Artificial , Water Purification/methods
5.
BMJ Open ; 12(4): e056637, 2022 04 21.
Article in English | MEDLINE | ID: mdl-35450905

ABSTRACT

OBJECTIVES: Patients with cancer are at higher risk for severe COVID-19 infection. COVID-19 surveillance of workers in oncological centres is crucial to assess infection burden and prevent transmission. We estimate the SARS-CoV-2 seroprevalence among healthcare workers (HCWs) of a comprehensive cancer centre in Catalonia, Spain, and analyse its association with sociodemographic characteristics, exposure factors and behaviours. DESIGN: Cross-sectional study (21 May 2020-26 June 2020). SETTING: A comprehensive cancer centre (Institut Català d'Oncologia) in Catalonia, Spain. PARTICIPANTS: All HCWs (N=1969) were invited to complete an online self-administered epidemiological survey and provide a blood sample for SARS-CoV-2 antibodies detection. PRIMARY OUTCOME MEASURE: Prevalence (%) and 95% CIs of seropositivity together with adjusted prevalence ratios (aPR) and 95% CI were estimated. RESULTS: A total of 1266 HCWs filled the survey (participation rate: 64.0%) and 1238 underwent serological testing (97.8%). The median age was 43.7 years (p25-p75: 34.8-51.0 years), 76.0% were female, 52.0% were nursing or medical staff and 79.0% worked on-site during the pandemic period. SARS-CoV-2 seroprevalence was 8.9% (95% CI 7.44% to 10.63%), with no differences by age and sex. No significant differences in terms of seroprevalence were observed between onsite workers and teleworkers. Seropositivity was associated with living with a person with COVID-19 (aPR 3.86, 95% CI 2.49 to 5.98). Among on-site workers, seropositive participants were twofold more likely to be nursing or medical staff. Nursing and medical staff working in a COVID-19 area showed a higher seroprevalence than other staff (aPR 2.45, 95% CI 1.08 to 5.52). CONCLUSIONS: At the end of the first wave of the pandemic in Spain, SARS-CoV-2 seroprevalence among Institut Català d'Oncologia HCW was lower than the reported in other Spanish hospitals. The main risk factors were sharing household with infected people and contact with COVID-19 patients and colleagues. Strengthening preventive measures and health education among HCW is fundamental.


Subject(s)
COVID-19 , Neoplasms , Adult , Antibodies, Viral , COVID-19/epidemiology , Cross-Sectional Studies , Female , Health Personnel , Humans , Male , Neoplasms/epidemiology , SARS-CoV-2 , Seroepidemiologic Studies , Spain/epidemiology
6.
J Cardiol ; 79(3): 417-422, 2022 03.
Article in English | MEDLINE | ID: mdl-34774385

ABSTRACT

PURPOSE: Patients undergoing cavotricuspid isthmus (CTI) ablation for typical flutter (AFL) have a high incidence of new onset atrial fibrillation (AF). We aimed to analyze the influence of PACE score to predict new onset AF in this subset of patients to stratify thromboembolic risk. METHODS: Between 2017 and 2019, patients undergoing CTI ablation for AFL and without history of AF were prospectively included. All patients were monitored continuously by implantable loop recorder and followed by remote monitoring. RESULTS: Overall 48 patients were included. New onset AF rate at 12 months was 56.3%. We observed two very strong independent predictors for new onset AF: a PACE score ≥ 30 (HR:6.9; 95% CI:1.71-27.91; p = 0.007) and an HV interval ≥ 55 (HR:11.86; 95% CI:2.57-54.8; p = 0.002). CONCLUSIONS: The incidence of newly diagnosed AF is high in patients with AFL after CTI ablation, and can occur early. A high PACE score and/or long HV interval predict even higher risk, and may be useful in the decision for empiric long-term anticoagulation.


Subject(s)
Atrial Fibrillation , Atrial Flutter , Catheter Ablation , Atrial Fibrillation/epidemiology , Atrial Fibrillation/etiology , Atrial Fibrillation/surgery , Atrial Flutter/epidemiology , Atrial Flutter/etiology , Catheter Ablation/adverse effects , Humans , Incidence , Treatment Outcome
8.
Europace ; 23(3): 456-463, 2021 03 08.
Article in English | MEDLINE | ID: mdl-33595062

ABSTRACT

AIMS: During the COVID-19 pandemic, concern regarding its effect on the management of non-communicable diseases has been raised. However, there are no data on the impact on cardiac implantable electronic devices (CIED) implantation rates. We aimed to determine the impact of SARS-CoV2 on the monthly incidence rates and type of pacemaker (PM) and implantable cardiac defibrillator (ICD) implantations in Catalonia before and after the declaration of the state of alarm in Spain on 14 March 2020. METHODS AND RESULTS: Data on new CIED implantations for 2017-20 were prospectively collected by nine hospitals in Catalonia. A mixed model with random intercepts corrected for time was used to estimate the change in monthly CIED implantations. Compared to the pre-COVID-19 period, an absolute decrease of 56.5% was observed (54.7% in PM and 63.7% in ICD) in CIED implantation rates. Total CIED implantations for 2017-19 and January and February 2020 was 250/month (>195 PM and >55 ICD), decreasing to 207 (161 PM and 46 ICD) in March and 131 (108 PM and 23 ICD) in April 2020. In April 2020, there was a significant fall of 185.25 CIED implantations compared to 2018 [95% confidence interval (CI) 129.6-240.9; P < 0.001] and of 188 CIED compared to 2019 (95% CI 132.3-243.7; P < 0.001). No significant differences in the type of PM or ICD were observed, nor in the indication for primary or secondary prevention. CONCLUSIONS: During the first wave of the COVID-19 pandemic, a substantial decrease in CIED implantations was observed in Catalonia. Our findings call for measures to avoid long-term social impact.


Subject(s)
COVID-19 , Defibrillators, Implantable/trends , Pacemaker, Artificial/trends , Practice Patterns, Physicians'/trends , Prosthesis Implantation/trends , Humans , Patient Safety , Prospective Studies , Prosthesis Implantation/instrumentation , Spain , Time Factors
9.
J Histochem Cytochem ; 68(6): 365-376, 2020 06.
Article in English | MEDLINE | ID: mdl-32496163

ABSTRACT

Autophagy has been involved in the pathogenesis of various lung diseases. However, it is not yet known whether autophagy plays a role in hypersensitivity pneumonitis (HP). HP is an interstitial lung disease resulting from exposure to a wide variety of antigens that provoke an exaggerated immune response in susceptible individuals. The aim of this study was to explore the localization of autophagy key proteins in lungs from HP patients and controls by immunohistochemistry and analyze their expression levels by immunoblot. Macrophages and epithelial cells were strongly positive for the autophagosome biomarker LC3B (microtubule-associated protein light chain 3 beta) in HP lungs compared with controls. A similar pattern was found for the autophagy receptor p62 and the enzyme ATG4B. Unexpectedly, nuclear p62 signal was also noticed in macrophages from HP lungs. Regarding ATG5 and ATG7 localization, we observed positive staining in neutrophils, vascular smooth muscle cells, and endothelial cells. Our findings provide for the first time evidence that proteins from the autophagy machinery are highly expressed in the lungs of HP patients and describe the specific cellular and subcellular localization of LC3B, p62, ATG4B, ATG5, and ATG7 in HP lungs.


Subject(s)
Alveolitis, Extrinsic Allergic/metabolism , Autophagy-Related Proteins/metabolism , Lung/metabolism , Autophagosomes/metabolism , Case-Control Studies , Female , Gene Expression Regulation , Humans , Immunohistochemistry , Male , Middle Aged , Protein Transport
10.
J Cardiovasc Electrophysiol ; 31(7): 1649-1657, 2020 07.
Article in English | MEDLINE | ID: mdl-32400073

ABSTRACT

BACKGROUND: The diagnostic accuracy of incremental atrial pacing (IP) to determine complete cavo-tricuspid isthmus (CTI) block during typical atrial flutter (AFL) ablation is limited by both an extensive/nonlinear ablation and/or the presence of intra-atrial conduction delay elsewhere in the right atrium. We examined the diagnostic performance of an IP variant based on the assessment of the atrial potentials adjacent to the ablation line which aims at overcoming both limitations. METHODS: From a prospective population of 108 consecutive patients, 15 were excluded due to observation of inconclusive CTI ablation potentials precluding for a straight comparison between the IP maneuver and its variant. In the remaining 93, IP was performed from the low lateral right atrium and the coronary sinus ostium, with the ablation catheter positioned both at the CTI line and adjacent (<5 mm) to its septal and lateral aspect. The IP variant consisted of measuring the interval between the two atrial electrograms situated on the same side of the ablation line, opposite to the pacing site, a ≤10 ms increase indicating complete CTI block. RESULTS: The IP maneuver and its variant were consistent with complete CTI block in 82/93 (88%) and 87/93 (93%) patients, respectively. Four patients had AFL recurrence during follow-up: 2/4 and 4/4 had been adequately classified as incomplete block by the IP maneuver and its variant, respectively. Twenty-three patients (24%) had significant intra-atrial conduction delay elsewhere in the right atrium. The IP maneuver and its variant were suggestive of an incomplete CTI block in 11/23 and 4/23 in this setting (P = .028), with the later best predicting subsequent AFL relapses (2/12 vs 2/4, P = .01). CONCLUSIONS: The IP variant, which was designed to overcome the limitations of the conventional IP maneuver, accurately distinguishes complete from incomplete CTI block and helps to predict AFL recurrences after ablation.


Subject(s)
Atrial Flutter , Catheter Ablation , Atrial Flutter/diagnosis , Atrial Flutter/surgery , Electrophysiologic Techniques, Cardiac , Humans , Prospective Studies , Treatment Outcome
11.
J Nurs Scholarsh ; 51(4): 449-458, 2019 07.
Article in English | MEDLINE | ID: mdl-30874373

ABSTRACT

PURPOSE: To assess changes in the self-reported performance of smoking cessation interventions according to the 5A's model (Ask; Advise; Assess; Assist; and Arrange follow-up) among clinicians; and to identify the main barriers and facilitators in smoking cessation implementation before and after an online smoking cessation training program. DESIGN: Pre-post evaluation. METHODS: We assessed self-reported smoking cessation interventions in the implementation of the 5A's model among clinicians working in Catalan hospitals (Spain). In addition, we assessed individual-, behavioral-, and organizational-level factors that act as barriers and facilitators in the implementation of the 5A's model. We used a questionnaire of 63 items reflecting each of the 5A's performance (scored from 0 = none to 10 = most possible). The questionnaire was completed both immediately before and 6 months after the training. We analyzed the data of those participants who had a clinical role and answered pre- and post-questionnaires. We used the nonparametric test for paired data (Wilcoxon) to examine changes in scores. FINDINGS: A total of 127 clinicians completed the pre-post questionnaire; 63.0% were registered nurses, 17.3% were nursing assistants, 7.9% were physicians, and 11.8% were other professionals (p < .001). Overall, there were significant increases in the implementation of the assist component (from a score of 4.5 to 5.2; p < .003) and arrange a follow-up component (from 3.6 to 4.5; p < .001) of the intervention. Scores in the perception of the level of overall preparation, preparedness in using smoking cessation drugs, level of competence, and organizational recognition improved (p < .001) at the follow-up; however, the score in the perception that implementing smoking cessation is part of their job decreased (from 6.3 to 4.4; p < .001). CONCLUSIONS: The online training had a positive impact on the implementation of assist and arrange follow-up components. Although self-preparedness in the management of smokers increased, the motivation and involvement of key professionals decreased. Organizational factors related to the incorporation of resources (such as protocols, records, etc.) should be improved for the correct progression of smoking cessation interventions within the institutions. CLINICAL RELEVANCE: Smoking cessation training programs should incorporate some motivational content to increase the engagement of health professionals in smoking cessation interventions in their clinical practice.


Subject(s)
Health Personnel/education , Hospitals/statistics & numerical data , Smoking Cessation/methods , Adult , Female , Humans , Male , Self Report , Spain , Surveys and Questionnaires
12.
Am J Physiol Lung Cell Mol Physiol ; 316(5): L961-L976, 2019 05 01.
Article in English | MEDLINE | ID: mdl-30785343

ABSTRACT

Matrix metalloprotease 13 (MMP13) deficiency in pulmonary fibrosis has described contradictory phenotypes on inflammatory and fibrotic responses after lung injury, and its role during lung fibrosis resolution is still undefined. MMP13 has been considered the main collagenase in rodents, and the remodeling of fibrillar collagen is widely attributed to the action of this enzyme. In this study we aimed to explore the role of MMP13 during lung fibrosis progression and resolution. Lung fibrosis was induced by intratracheal instillation, and inflammatory, fibrotic, and resolution stages were evaluated in Mmp13-null and wild-type (WT) mice. Bronchoalveolar lavage fluid was taken for cytokine array analysis and activity of gelatinases. Our results showed that MMP13 is upregulated mainly during two stages after lung injury, inflammation and resolution of fibrosis, and it is mainly expressed by alveolar and interstitial macrophages. Mmp13-null mice exhibited more extensive inflammation at 7 days after bleomycin treatment, and it was characterized by increased macrophage infiltration and significant alterations in proinflammatory cytokines. We also documented that Mmp13-deficient mice experienced more severe and prolonged lung fibrosis compared with WT mice. Delayed resolution in Mmp13-deficient lungs was characterized by a decreased overall collagenolytic activity and persistent fibrotic foci associated with emphysema-like areas. Together, our findings indicate that MMP13 plays an antifibrotic role and its activity is crucial in lung repair and restoration of tissue integrity during fibrosis resolution.


Subject(s)
Bleomycin/adverse effects , Gene Expression Regulation, Enzymologic/drug effects , Matrix Metalloproteinase 13 , Pulmonary Fibrosis , Up-Regulation/drug effects , Animals , Bleomycin/pharmacology , Bronchoalveolar Lavage , Cytokines/genetics , Cytokines/metabolism , Inflammation/enzymology , Inflammation/genetics , Inflammation/metabolism , Inflammation/pathology , Matrix Metalloproteinase 13/biosynthesis , Matrix Metalloproteinase 13/genetics , Mice , Mice, Mutant Strains , Pulmonary Fibrosis/chemically induced , Pulmonary Fibrosis/enzymology , Pulmonary Fibrosis/genetics , Pulmonary Fibrosis/pathology
13.
J Interv Card Electrophysiol ; 55(1): 17-26, 2019 Jun.
Article in English | MEDLINE | ID: mdl-30411175

ABSTRACT

PURPOSE: Cryoballoon ablation (CBA) has become a standard treatment for recurrent atrial fibrillation (AF). There is need for improved CBA protocols. We aimed to demonstrate that a new protocol including minimum temperature (minT) reached could reduce procedure times and complications. METHODS: A new double factor protocol (DFP), based on the performance of one single shot per vein with variable duration, and conditional bonus shot, determined by time-to-effect (TTE) and minT, was compared with the conventional protocol (CP), with at least two shots per vein. Procedure parameters, complications, and efficacy were compared. RESULTS: We prospectively included 88 consecutive patients treated with the DFP. These were compared to the previous consecutive 69 patients treated with CP. All procedures were performed with 28-mm second-generation balloon. Acute pulmonary vein (PV) isolation was similar (98.6% vs. 98.9% in CP vs. DFP, p = 0.687). Procedure and ablation times favored DFP over CP (120 vs. 134 min, p = 0.003; and 1051 vs. 1475 s, p < 0.001; respectively). A composite of major and minor complications was significantly reduced in the DFP compared to the CP (18.8% vs. 6.8%, p = 0.02; respectively). Within a follow-up of 18 months, freedom from AF was 79.7% in CP and 78.4% in DFP (Log-rank 0.501). Paroxysmal AF and absence of PV potentials predicted better arrhythmia outcomes (HR 2.14 for paroxysmal vs. persistent, p = 0.031; and HR 1.61 for absence vs. presence of PV potentials, p = 0.01). CONCLUSIONS: The novel DFP results in reduced complication rates and procedure times, with similar success rates compared with a conventional strategy.


Subject(s)
Atrial Fibrillation/surgery , Cryosurgery/methods , Postoperative Complications/prevention & control , Female , Humans , Male , Middle Aged , Operative Time , Prospective Studies , Pulmonary Veins/surgery , Temperature , Treatment Outcome
14.
Ginecol. obstet. Méx ; 87(8): 506-512, ene. 2019. tab, graf
Article in Spanish | LILACS-Express | LILACS | ID: biblio-1286652

ABSTRACT

Resumen OBJETIVO: Exponer los desenlaces de dos técnicas de sutura hemostática uterina para controlar la hemorragia obstétrica. MATERIALES Y MÉTODOS: Estudio prospectivo, observacional y longitudinal, llevado a cabo en tres unidades hospitalarias de Guanajuato, México, del 1 de enero al 30 de noviembre de 2018. Se incluyeron pacientes con hemorragia transcesárea y posparto. En las primeras se aplicó la técnica de B-Lynch y en las segundas la de Hayman. Se analizaron las variables: 1) cantidad de hemorragia antes y después de aplicar la sutura, 2) tiempo del procedimiento, 3) concentración de hemoglobina al ingreso a la unidad de atención, 1 hora después de la hemorragia y 24 horas posteriores a la intervención quirúrgica, 4) desenlace de las técnicas y 5) complicaciones. Para el análisis de los datos se utilizó el programa SPSS versión 22 para Windows. RESULTADOS: Se registraron 34 pacientes: 26 con aplicación de la técnica de sutura B-Lynch y 8 con la técnica de Hayman. La pérdida sanguínea después de la aplicación de las técnicas fue menor (p < 0.001). El tiempo entre el diagnóstico de hemorragia y la aplicación de la sutura fue de 11.5 ± 5.9 minutos. La concentración de hemoglobina al ingreso al hospital y 1 h posterior a la hemorragia fue significativamente menor (p < 0.01) versus 24 h después (p < 0.05) 30 de 34 pacientes tuvieron reacción favorable al tratamiento quirúrgico. Cuatro mujeres requirieron procedimientos adicionales para el control de la hemorragia. No se reportaron complicaciones ni muertes maternas asociadas con las técnicas de sutura. CONCLUSIONES: Las técnicas de sutura uterina representan un procedimiento útil, rápido y sin complicaciones para el control de la hemorragia obstétrica.


Abstract OBJECTIVE: To present the results obtained with two techniques of uterine hemostatic sutures for the control of obstetric hemorrhage. MATERIALS AND METHODS: Prospective, observational, longitudinal study in three hospital units of the 1st. from January to November 30, 2018. Thirty-four patients with postpartum and transcesarean hemorrhage were included. The postpartum patients underwent Hayman technique and the B-Lynch technique. The following were analyzed: 1) amount of hemorrhage before and after the sutures, 2) time between diagnosis and placement, 3) hemoglobin levels at admission to the care unit, 1 hour after the hemorrhage and 24 hours after treatment, 4) results with the two techniques and 5) complications. Statistical analysis of all these variables was performed with SPSS, 22 version. RESULTS: A total of 34 patients were registered: 26 sutures performed with B-Lynch technique and 8 with Hayman technique. The amount of bleeding after the application was lower (p <0.001). The time between diagnosis of bleeding and placement was 11.5 + 5.9 minutes. The hemoglobin levels at admission to the hospital and one hour after the hemorrhage were significantly lower (p <0.01) and 24 hours later (p <0.05). In 30/34 of cases, a favorable response to surgical treatment was achieved. In four cases, another procedure was required to control bleeding. There were no complications with the use of sutures or maternal deaths. CONCLUSIONS: The use of uterine sutures was a useful, fast and uncomplicated therapy for the control of obstetric hemorrhage.

15.
Aging (Albany NY) ; 10(8): 2098-2112, 2018 Aug 27.
Article in English | MEDLINE | ID: mdl-30147026

ABSTRACT

Aging is the main risk factor for the development of idiopathic pulmonary fibrosis (IPF), a progressive and usually lethal lung disorder. Although the pathogenic mechanisms are uncertain, endoplasmic reticulum (ER) stress and impaired proteostasis that have been linked with aging are strongly associated with the pathogenesis of IPF. Using the Atg4b-deficient mice as a model, that partially reproduces the autophagy deficient conditions reported in aging and IPF lungs, we show for the first time how autophagy impairment and ER stress induction, contribute simultaneously to development of lung fibrosis in vivo. Increased expression of ER stress markers, inflammation and apoptosis of alveolar epithelial cells were observed in Atg4b-deficient mice compared to WT mice, when treated with the ER stress inducer tunicamycin. After tunicamycin treatment, Atg4b null lungs showed accumulation of its substrate LC3-I, demonstrating that these mice failed to induce autophagy despite the ER stress conditions. We also showed that compromised autophagy in lungs from Atg4b null mice is associated with exacerbated lung damage, epithelial apoptosis and the development of lung fibrosis at 21 days after tunicamycin treatment. Our findings indicate that ATG4B protein and autophagy are essential to mitigate ER stress and to prevent tunicamycin-induced epithelial apoptosis and lung fibrosis.


Subject(s)
Autophagy-Related Proteins/metabolism , Autophagy/drug effects , Cysteine Endopeptidases/metabolism , Endoplasmic Reticulum/physiology , Epithelial Cells/physiology , Animals , Autophagy/physiology , Autophagy-Related Proteins/genetics , Cell Line , Cysteine Endopeptidases/genetics , Epithelial Cells/drug effects , Gene Expression Regulation/drug effects , Lung/cytology , Respiratory Mucosa/cytology , Tunicamycin/pharmacology
16.
Am J Respir Cell Mol Biol ; 59(1): 77-86, 2018 07.
Article in English | MEDLINE | ID: mdl-29373068

ABSTRACT

Idiopathic pulmonary fibrosis (IPF) is a chronic and progressive aging-associated disease of unknown etiology. A growing body of evidence indicates that aberrant activated alveolar epithelial cells induce the expansion and activation of the fibroblast population, leading to the destruction of the lung architecture. Some matrix metalloproteinases (MMPs) are upregulated in IPF, indicating that they may be important in the pathogenesis and/or progression of IPF. In the present study, we examined the expression of MMP28 in this disease and evaluated its functional effects in two alveolar epithelial cell lines and in human primary bronchial epithelial cells. We found that the enzyme is expressed in bronchial (apical and cytoplasmic localization) and alveolar (cytoplasmic and nuclear localization) epithelial cells in two different groups of patients with IPF. In vitro MMP28 epithelial silencing decreased the proliferation rate and delayed wound closing, whereas overexpression showed opposite effects, protecting from apoptosis and enhanced epithelial-mesenchymal transition. Our findings demonstrate that MMP28 is upregulated in epithelial cells from IPF lungs, where it may play a role in increasing the proliferative and migratory phenotype in a catalysis-dependent manner.


Subject(s)
Cell Nucleus/metabolism , Epithelium/metabolism , Idiopathic Pulmonary Fibrosis/enzymology , Idiopathic Pulmonary Fibrosis/genetics , Matrix Metalloproteinases, Secreted/genetics , Pulmonary Alveoli/pathology , Up-Regulation/genetics , A549 Cells , Animals , Apoptosis , Biocatalysis , Cell Movement , Cell Proliferation , Cytoprotection , Disease Models, Animal , Epithelial Cells/metabolism , Epithelial Cells/pathology , Epithelial-Mesenchymal Transition , Epithelium/pathology , Gene Silencing , Humans , Matrix Metalloproteinases, Secreted/metabolism , Protein Transport , Rats
18.
Chemistry ; 24(12): 2826-2831, 2018 Feb 26.
Article in English | MEDLINE | ID: mdl-29336510

ABSTRACT

A detailed investigation of the hierarchy of asymmetry operating in the self-assembly of achiral (1) and chiral ((S)-2 and (R)-3) 1,3,5-triphenylbenzenetricarboxamides (TPBAs) is reported. The aggregation of these TPBAs is conditioned by the point chirality at the peripheral side chains for (S)-2 and (R)-3. An efficient helix-to-helix interaction that goes further in the organization of fibrillar bundles is experimentally detected and theoretically supported only for the achiral TPBA 1. The effective interdigitation of the achiral aliphatic side chains produces a social self-sorting to form preferentially heterochiral macromolecular aggregates.

19.
Tob Induc Dis ; 16: 34, 2018.
Article in English | MEDLINE | ID: mdl-31516433

ABSTRACT

INTRODUCTION: A comprehensive smoking ban was recently enacted for acute-care hospital campuses in Spain. The aim of this study was to assess the prevalence and patterns of smoking among inpatients before and during hospitalization. METHODS: Multi-center cross-sectional study was conducted in 13 hospitals in the province of Barcelona, Spain from May 2014 to May 2015. Participants were adults who provided informed consent. The sample size was calculated to be representative of each hospital (prevalence 29.4%, precision ± 5%, error 5%). We approached 1228 subjects, 888 accepted to participate and 170 were replaced (were not available or declined to participate). Final sample comprised 1047 subjects. We used a computer-assisted personal interview system to collect data, including sociodemographic variables and use of tobacco before and during hospitalization. Smoking status was validated with exhaled carbon monoxide. We calculated overall tobacco prevalence and investigated associations with participant and center characteristics. We performed multiple polytomous and multilevel logistic regression analyses to estimate odds ratios (ORs) and 95% confidence intervals (CIs), with adjustments for potential confounders. RESULTS: In all, 20.5% (95% CI: 18.1-23.0) of hospitalized patients were smokers. Smoking was most common among men (aOR=7.47; 95% CI: 4.88-11.43), young age groups (18-64 years), and individuals with primary or less than primary education (aOR=2.76; 95% CI: 1.44-5.28). Of the smokers, 97.2% were daily consumers of whom 44.9% had medium nicotine dependence. Of all smokers, three-quarters expressed a wish to quit, and one-quarter admitted to consuming tobacco during hospitalization. CONCLUSIONS: Our findings indicate the need to offer smoking cessation interventions among hospitalized patients in all units and service areas, to avoid infringements and increase patient safety, hospital efficiency, and improve clinical outcomes. Hospitalization represents a promising window for initiating smoking interventions addressed to all patients admitted to smoke-free hospitals, specially after applying a smoke-free campus ban.

SELECTION OF CITATIONS
SEARCH DETAIL
...